Alopecia Areata-Like Presentations With Mogamulizumab Therapy

    September 2023 in “ JAAD case reports
    Colin M. Kincaid, Ajay Sharma, Bonnie Lee, Lauren Pinter‐Brown, Janellen Smith, Kenneth G. Linden, Natasha Atanaskova Mesinkovska
    Image of study
    TLDR Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.
    Mogamulizumab, used for treating mycosis fungoides and Sézary syndrome, has been linked to alopecia areata-like presentations. A 71-year-old man with Sézary syndrome developed widespread alopecia and follicular dermatitis after treatment with mogamulizumab. Histopathology showed a predominance of CD8+ T-cells, indicating drug-induced alopecia. After discontinuing mogamulizumab, the patient's Sézary syndrome remained in remission, and his rash resolved. This suggests that mogamulizumab-associated alopecia may be a positive prognostic factor, though further studies are needed.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 1000+ results

    Related Research

    1 / 1 results